Besides, in both paired primaries and metastases of most CRCs, the merged CCFs of mutations in CRC driver genes including APC, KRAS, and TP53 were >0.6, suggesting that they may contribute to CRC tumorigenesis and metastasis. This evidence concerns the gene KRAS and colorectal carcinoma.